| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.60e-10 | 20 | 102 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.63e-08 | 36 | 102 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.03e-07 | 50 | 102 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.89e-07 | 53 | 102 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RGPD2 RANBP2 RGPD8 ARHGAP26 RGPD1 ARHGAP11A RGPD3 RGPD5 | 1.31e-05 | 279 | 102 | 9 | GO:0005096 |
| GeneOntologyMolecularFunction | guanylate kinase activity | 2.07e-05 | 11 | 102 | 3 | GO:0004385 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 4.02e-05 | 123 | 102 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CNTN4 FLNB CD2AP SVEP1 EHD4 EPS15L1 P4HB AHNAK CNTN5 DLG1 DMD CDH10 | 5.49e-05 | 599 | 102 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | isomerase activity | 5.82e-05 | 192 | 102 | 7 | GO:0016853 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RGPD2 RANBP2 HTR2A RGPD8 ARHGAP26 RGPD1 RICTOR ARHGAP11A WNK1 RGPD3 RGPD5 | 1.30e-04 | 656 | 102 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 2.13e-04 | 23 | 102 | 3 | GO:0050145 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.42e-04 | 321 | 102 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 ARHGAP26 RGPD1 GBP2 ARHGAP11A RGPD3 RGPD5 | 2.69e-04 | 507 | 102 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 ARHGAP26 RGPD1 GBP2 ARHGAP11A RGPD3 RGPD5 | 2.69e-04 | 507 | 102 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | calcium ion binding | HSP90B1 FAT3 SVEP1 CRB1 EHD4 MYOF EPS15L1 EYS HMCN2 EDEM1 ATP2B2 CDH10 | 4.36e-04 | 749 | 102 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | GTPase binding | 5.19e-04 | 360 | 102 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 7.90e-04 | 81 | 102 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 1.20e-03 | 41 | 102 | 3 | GO:0016776 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.38e-03 | 11 | 102 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.38e-03 | 11 | 102 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.78e-03 | 339 | 102 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 1.78e-03 | 47 | 102 | 3 | GO:0019205 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.94e-03 | 13 | 102 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.36e-03 | 264 | 102 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 3.10e-03 | 57 | 102 | 3 | GO:0015459 | |
| GeneOntologyMolecularFunction | actin binding | 3.17e-03 | 479 | 102 | 8 | GO:0003779 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.11e-12 | 9 | 103 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.76e-12 | 10 | 103 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 4.63e-12 | 20 | 103 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.23e-11 | 13 | 103 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.89e-11 | 14 | 103 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.20e-09 | 54 | 103 | 7 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.25e-08 | 38 | 103 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.68e-08 | 145 | 103 | 9 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.35e-07 | 175 | 103 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.35e-07 | 175 | 103 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.71e-07 | 178 | 103 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.76e-07 | 185 | 103 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.43e-06 | 217 | 103 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 1.47e-06 | 71 | 103 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.50e-06 | 121 | 103 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 RGPD2 RANBP2 HSP90B1 RGPD8 COPG1 UBXN6 RGPD1 TACC2 WNK1 EHD4 EPS15L1 C12orf50 P4HB SUPT6H RGPD3 SEC16A DLG2 EDEM1 DYNC1H1 SORL1 RGPD5 | 3.71e-06 | 1496 | 103 | 22 | GO:0046907 |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | RGPD4 RGPD2 RANBP2 SPAM1 HTR2A RGPD8 ATG2B RGPD1 PGD AKR7A2 MYOF RGPD3 FUT2 EDEM1 | 4.00e-06 | 646 | 103 | 14 | GO:0005975 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.41e-06 | 249 | 103 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 RGPD2 RANBP2 HTR2A RGPD8 CD2AP RGPD1 GBP2 WNK1 DDX1 ZDHHC15 RGPD3 SEC16A DLG1 DLG2 EDEM1 SORL1 RGPD5 | 7.00e-06 | 1091 | 103 | 18 | GO:0033365 |
| GeneOntologyBiologicalProcess | GDP metabolic process | 1.94e-05 | 11 | 103 | 3 | GO:0046710 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 WNK1 C12orf50 SUPT6H RGPD3 RGPD5 | 1.97e-05 | 378 | 103 | 10 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 WNK1 C12orf50 SUPT6H RGPD3 RGPD5 | 1.97e-05 | 378 | 103 | 10 | GO:0006913 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.98e-05 | 111 | 103 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 2.43e-05 | 115 | 103 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 RGPD2 RANBP2 HTR2A RGPD8 RGPD1 RICTOR WNK1 EHD4 SGK2 PTPN4 ZDHHC15 P4HB RGPD3 DMD ATP2B4 | 2.61e-05 | 976 | 103 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | protein folding | 3.28e-05 | 246 | 103 | 8 | GO:0006457 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 3.37e-05 | 247 | 103 | 8 | GO:0016051 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 5.27e-05 | 132 | 103 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 5.58e-05 | 195 | 103 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 5.73e-05 | 134 | 103 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | import into nucleus | 6.76e-05 | 201 | 103 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 RGPD2 RANBP2 HSP90B1 RGPD8 COPG1 RGPD1 RGPD3 SEC16A DLG2 EDEM1 SORL1 RGPD5 | 8.04e-05 | 740 | 103 | 13 | GO:0006886 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 8.42e-05 | 362 | 103 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | cell junction organization | CNTN4 CD2AP FBF1 ADGRB1 SVEP1 ZDHHC15 HMCN2 CNTN5 C1QC DLG1 DLG2 POLDIP2 ATP2B2 CDH10 TBX5 | 9.68e-05 | 974 | 103 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | protein exit from endoplasmic reticulum | 1.22e-04 | 51 | 103 | 4 | GO:0032527 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 1.61e-04 | 231 | 103 | 7 | GO:0006109 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 1.64e-04 | 310 | 103 | 8 | GO:0005996 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ZDHHC15 RGPD3 EDEM1 SORL1 RGPD5 | 2.55e-04 | 515 | 103 | 10 | GO:0072594 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CNTN4 FLNB FAT3 CD2AP ADGRB1 GAS7 CFAP43 CRB1 ZDHHC15 HMCN2 CNTN5 DLG1 DMD CAMSAP1 ATP2B2 CDH10 | 2.75e-04 | 1194 | 103 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 3.33e-04 | 66 | 103 | 4 | GO:0031122 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate metabolic process | 3.53e-04 | 67 | 103 | 4 | GO:0009161 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transport | 3.95e-04 | 69 | 103 | 4 | GO:1902305 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 4.02e-04 | 29 | 103 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | cell recognition | 4.79e-04 | 198 | 103 | 6 | GO:0008037 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 5.60e-04 | 284 | 103 | 7 | GO:0019318 | |
| GeneOntologyBiologicalProcess | GMP metabolic process | 5.92e-04 | 33 | 103 | 3 | GO:0046037 | |
| GeneOntologyBiologicalProcess | synapse organization | CNTN4 CD2AP ADGRB1 ZDHHC15 HMCN2 CNTN5 C1QC DLG1 DLG2 ATP2B2 CDH10 | 6.25e-04 | 685 | 103 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-cysteine S-nitrosylation | 6.78e-04 | 8 | 103 | 2 | GO:1902083 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 6.78e-04 | 8 | 103 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion import | 8.69e-04 | 9 | 103 | 2 | GO:1903286 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 8.69e-04 | 9 | 103 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CNTN4 HTR2A FAT3 CD2AP WNK1 SVEP1 CRB1 HMCN2 CNTN5 LPP SMARCB1 DLG1 DLG2 CDH10 | 9.22e-04 | 1077 | 103 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | FLII HSP90B1 CD2AP GAS7 COL5A3 RICTOR TACC2 NEDD1 ANTXR2 ANKRD1 DLG1 CAMSAP1 DYNC1H1 | 9.53e-04 | 957 | 103 | 13 | GO:0097435 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 9.66e-04 | 405 | 103 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 9.90e-04 | 313 | 103 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate metabolic process | 9.91e-04 | 88 | 103 | 4 | GO:0009123 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.03e-03 | 153 | 103 | 5 | GO:0051208 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.43e-13 | 8 | 103 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.55e-12 | 10 | 103 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.59e-11 | 14 | 103 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.19e-10 | 18 | 103 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.53e-10 | 20 | 103 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 6.31e-10 | 21 | 103 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 RGPD2 RANBP2 HSP90B1 CHERP RGPD8 CD2AP ANGEL1 ADGRB1 RGPD1 GBP2 CMYA5 EHD4 RGPD3 SEC16A DLG1 DAAM1 DMD SORL1 | 1.32e-07 | 934 | 103 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | inclusion body | 3.07e-07 | 90 | 103 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 6.75e-07 | 101 | 103 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | anchoring junction | FLII FLNB HSP90B1 ARHGAP26 CD2AP FBF1 ADGRB1 MAGI3 CRB1 P4HB AHNAK LPP DLG1 DLG2 POLDIP2 DMD CDH10 | 5.39e-06 | 976 | 103 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD2 RANBP2 RGPD8 CD2AP RGPD1 AKR7A2 MYOF RGPD3 DYNC1H1 SORL1 RGPD5 | 2.02e-05 | 560 | 103 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | synaptic membrane | HTR2A ADGRB1 CNTN5 C1QC DLG1 DLG2 DMD USP48 ATP2B2 ATP2B4 CDH10 | 1.42e-04 | 583 | 103 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.62e-04 | 164 | 103 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | costamere | 1.67e-04 | 22 | 103 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.77e-04 | 405 | 103 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.44e-04 | 443 | 103 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.46e-04 | 277 | 103 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | tRNA-splicing ligase complex | 6.60e-04 | 8 | 103 | 2 | GO:0072669 | |
| GeneOntologyCellularComponent | cell-cell junction | 6.75e-04 | 591 | 103 | 10 | GO:0005911 | |
| GeneOntologyCellularComponent | fibrillar center | 1.06e-03 | 156 | 103 | 5 | GO:0001650 | |
| GeneOntologyCellularComponent | focal adhesion | 1.32e-03 | 431 | 103 | 8 | GO:0005925 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.71e-03 | 349 | 103 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | endoplasmic reticulum chaperone complex | 1.81e-03 | 13 | 103 | 2 | GO:0034663 | |
| GeneOntologyCellularComponent | microtubule organizing center | FLII CD2AP FBF1 UBXN6 TACC2 NEDD1 MYOF EYS FANK1 DAAM1 CAMSAP1 DYNC1H1 | 1.88e-03 | 919 | 103 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | supramolecular fiber | FLNB HTR2A CD2AP FBF1 GAS7 COL5A3 CMYA5 AHNAK ANKRD1 DLG1 DMD CAMSAP1 ATP2B4 DYNC1H1 | 1.91e-03 | 1179 | 103 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | FLNB HTR2A CD2AP FBF1 GAS7 COL5A3 CMYA5 AHNAK ANKRD1 DLG1 DMD CAMSAP1 ATP2B4 DYNC1H1 | 2.04e-03 | 1187 | 103 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | neurofilament | 2.11e-03 | 14 | 103 | 2 | GO:0005883 | |
| GeneOntologyCellularComponent | nuclear envelope lumen | 2.11e-03 | 14 | 103 | 2 | GO:0005641 | |
| GeneOntologyCellularComponent | membrane raft | 2.11e-03 | 362 | 103 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 RGPD2 RANBP2 HSP90B1 CHERP RGPD8 COPG1 ATG2B RGPD1 ANTXR2 RGPD3 SEC16A DLG1 EDEM1 SORL1 | 2.12e-03 | 1327 | 103 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | membrane microdomain | 2.17e-03 | 364 | 103 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | myofibril | 2.33e-03 | 273 | 103 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | sarcolemma | 2.51e-03 | 190 | 103 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.15e-03 | 290 | 103 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.31e-03 | 293 | 103 | 6 | GO:0030658 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.43e-03 | 503 | 103 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | transport vesicle | 4.15e-03 | 519 | 103 | 8 | GO:0030133 | |
| GeneOntologyCellularComponent | presynapse | HTR2A MYOF EPS15L1 CNTN5 C1QC DLG1 DLG2 DMD ATP2B2 ATP2B4 CDH10 | 4.27e-03 | 886 | 103 | 11 | GO:0098793 |
| MousePheno | abnormal morula morphology | 1.99e-10 | 26 | 89 | 7 | MP:0012058 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 4.27e-10 | 16 | 89 | 6 | MP:0003701 | |
| MousePheno | decreased tumor latency | 2.95e-08 | 30 | 89 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 3.64e-08 | 31 | 89 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 6.54e-08 | 34 | 89 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 1.55e-07 | 39 | 89 | 6 | MP:0012128 | |
| MousePheno | aneuploidy | 2.35e-06 | 61 | 89 | 6 | MP:0004024 | |
| MousePheno | increased sarcoma incidence | 3.78e-06 | 102 | 89 | 7 | MP:0002032 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 5.20e-06 | 107 | 89 | 7 | MP:0003694 | |
| MousePheno | increased hepatocellular carcinoma incidence | 5.31e-06 | 70 | 89 | 6 | MP:0003331 | |
| MousePheno | abnormal blastocyst hatching | 7.47e-06 | 113 | 89 | 7 | MP:0003693 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 7.96e-06 | 160 | 89 | 8 | MP:0005659 | |
| MousePheno | increased lung carcinoma incidence | 9.99e-06 | 78 | 89 | 6 | MP:0008714 | |
| MousePheno | abnormal mitosis | 1.69e-05 | 128 | 89 | 7 | MP:0004046 | |
| MousePheno | abnormal chromosome number | 1.76e-05 | 86 | 89 | 6 | MP:0004023 | |
| MousePheno | decreased susceptibility to weight gain | 2.38e-05 | 186 | 89 | 8 | MP:0010182 | |
| MousePheno | increased energy expenditure | 3.46e-05 | 196 | 89 | 8 | MP:0004889 | |
| MousePheno | enlarged epididymis | 3.92e-05 | 99 | 89 | 6 | MP:0004931 | |
| MousePheno | prolonged P wave | 5.27e-05 | 12 | 89 | 3 | MP:0004071 | |
| MousePheno | increased respiratory system tumor incidence | 6.07e-05 | 107 | 89 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 6.07e-05 | 107 | 89 | 6 | MP:0008014 | |
| MousePheno | increased hepatobiliary system tumor incidence | 7.45e-05 | 111 | 89 | 6 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 7.45e-05 | 111 | 89 | 6 | MP:0008019 | |
| MousePheno | abnormal limb muscle morphology | 9.98e-05 | 73 | 89 | 5 | MP:0021206 | |
| MousePheno | abnormal preimplantation embryo development | 1.08e-04 | 171 | 89 | 7 | MP:0009781 | |
| MousePheno | abnormal rod electrophysiology | 1.10e-04 | 119 | 89 | 6 | MP:0004021 | |
| MousePheno | abnormal middle cerebral artery morphology | 1.20e-04 | 3 | 89 | 2 | MP:0020487 | |
| MousePheno | abnormal chromosome morphology | 1.50e-04 | 126 | 89 | 6 | MP:0003702 | |
| MousePheno | abnormal susceptibility to weight gain | 1.51e-04 | 309 | 89 | 9 | MP:0011117 | |
| MousePheno | embryonic lethality before implantation | 1.52e-04 | 242 | 89 | 8 | MP:0006204 | |
| MousePheno | sinoatrial block | 1.90e-04 | 18 | 89 | 3 | MP:0010520 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.77e-04 | 141 | 89 | 6 | MP:0004499 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 3.09e-04 | 203 | 89 | 7 | MP:0011094 | |
| MousePheno | abnormal heart atrium size | 3.81e-04 | 54 | 89 | 4 | MP:0031576 | |
| MousePheno | abnormal soleus morphology | 4.58e-04 | 24 | 89 | 3 | MP:0003081 | |
| MousePheno | abnormal P wave | 4.58e-04 | 24 | 89 | 3 | MP:0004070 | |
| MousePheno | abnormal eye electrophysiology | 6.21e-04 | 228 | 89 | 7 | MP:0005551 | |
| MousePheno | abnormal epididymis size | 6.60e-04 | 166 | 89 | 6 | MP:0004926 | |
| MousePheno | increased malignant tumor incidence | 7.80e-04 | 237 | 89 | 7 | MP:0002018 | |
| MousePheno | increased incidence of induced tumors | 8.19e-04 | 173 | 89 | 6 | MP:0002021 | |
| MousePheno | abnormal energy expenditure | 8.47e-04 | 313 | 89 | 8 | MP:0005450 | |
| Domain | Ran_BP1 | 9.10e-14 | 12 | 102 | 7 | PF00638 | |
| Domain | RANBD1 | 9.10e-14 | 12 | 102 | 7 | PS50196 | |
| Domain | RanBD | 1.96e-13 | 13 | 102 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 1.96e-13 | 13 | 102 | 7 | IPR000156 | |
| Domain | Grip | 1.03e-11 | 11 | 102 | 6 | SM00755 | |
| Domain | GRIP | 1.03e-11 | 11 | 102 | 6 | PF01465 | |
| Domain | GRIP_dom | 2.06e-11 | 12 | 102 | 6 | IPR000237 | |
| Domain | GRIP | 2.06e-11 | 12 | 102 | 6 | PS50913 | |
| Domain | Rab_bind | 9.16e-11 | 7 | 102 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 9.16e-11 | 7 | 102 | 5 | IPR032023 | |
| Domain | - | 1.09e-09 | 10 | 102 | 5 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 1.83e-05 | 150 | 102 | 7 | IPR013026 | |
| Domain | TPR_REGION | 3.38e-05 | 165 | 102 | 7 | PS50293 | |
| Domain | TPR | 3.38e-05 | 165 | 102 | 7 | PS50005 | |
| Domain | Laminin_G_2 | 6.59e-05 | 40 | 102 | 4 | PF02210 | |
| Domain | TPR | 7.56e-05 | 129 | 102 | 6 | SM00028 | |
| Domain | Guanylate_kinase_CS | 8.41e-05 | 16 | 102 | 3 | IPR020590 | |
| Domain | TPR_repeat | 8.96e-05 | 133 | 102 | 6 | IPR019734 | |
| Domain | LamG | 9.62e-05 | 44 | 102 | 4 | SM00282 | |
| Domain | - | 1.73e-04 | 95 | 102 | 5 | 2.60.120.200 | |
| Domain | ATP_Ca_trans_C | 1.76e-04 | 4 | 102 | 2 | IPR022141 | |
| Domain | MAGUK_N_PEST | 1.76e-04 | 4 | 102 | 2 | PF10608 | |
| Domain | PDZ_assoc | 1.76e-04 | 4 | 102 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 1.76e-04 | 4 | 102 | 2 | IPR019590 | |
| Domain | ATP_Ca_trans_C | 1.76e-04 | 4 | 102 | 2 | PF12424 | |
| Domain | PDZ_assoc | 1.76e-04 | 4 | 102 | 2 | IPR019583 | |
| Domain | MAGUK_N_PEST | 1.76e-04 | 4 | 102 | 2 | SM01277 | |
| Domain | DLG1 | 1.76e-04 | 4 | 102 | 2 | IPR016313 | |
| Domain | P-type_ATPase_IIB | 1.76e-04 | 4 | 102 | 2 | IPR006408 | |
| Domain | EGF_Ca-bd_CS | 1.91e-04 | 97 | 102 | 5 | IPR018097 | |
| Domain | ConA-like_dom | 1.99e-04 | 219 | 102 | 7 | IPR013320 | |
| Domain | EGF_CA | 2.10e-04 | 99 | 102 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.20e-04 | 100 | 102 | 5 | PS00010 | |
| Domain | GUANYLATE_KINASE_2 | 2.59e-04 | 23 | 102 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.59e-04 | 23 | 102 | 3 | PS00856 | |
| Domain | Laminin_G | 2.84e-04 | 58 | 102 | 4 | IPR001791 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.88e-04 | 106 | 102 | 5 | IPR000152 | |
| Domain | TPR-like_helical_dom | 2.91e-04 | 233 | 102 | 7 | IPR011990 | |
| Domain | Guanylate_kin | 3.75e-04 | 26 | 102 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 3.75e-04 | 26 | 102 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 3.75e-04 | 26 | 102 | 3 | IPR008144 | |
| Domain | GuKc | 3.75e-04 | 26 | 102 | 3 | SM00072 | |
| Domain | hEGF | 4.69e-04 | 28 | 102 | 3 | PF12661 | |
| Domain | PH_dom-like | 5.41e-04 | 426 | 102 | 9 | IPR011993 | |
| Domain | EGF_CA | 5.50e-04 | 122 | 102 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.93e-04 | 124 | 102 | 5 | IPR001881 | |
| Domain | - | 9.60e-04 | 207 | 102 | 6 | 1.25.40.10 | |
| Domain | PDZ | 1.06e-03 | 141 | 102 | 5 | PF00595 | |
| Domain | LAM_G_DOMAIN | 1.16e-03 | 38 | 102 | 3 | PS50025 | |
| Domain | EF-hand_4 | 1.29e-03 | 10 | 102 | 2 | PF12763 | |
| Domain | PDZ | 1.31e-03 | 148 | 102 | 5 | SM00228 | |
| Domain | - | 1.36e-03 | 391 | 102 | 8 | 2.30.29.30 | |
| Domain | - | 1.39e-03 | 150 | 102 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.43e-03 | 151 | 102 | 5 | PS50106 | |
| Domain | PDZ | 1.48e-03 | 152 | 102 | 5 | IPR001478 | |
| Domain | TPR_1 | 1.50e-03 | 90 | 102 | 4 | IPR001440 | |
| Domain | TPR_1 | 1.50e-03 | 90 | 102 | 4 | PF00515 | |
| Domain | EH | 1.57e-03 | 11 | 102 | 2 | PS50031 | |
| Domain | EH | 1.57e-03 | 11 | 102 | 2 | SM00027 | |
| Domain | EH_dom | 1.57e-03 | 11 | 102 | 2 | IPR000261 | |
| Domain | EGF_3 | 1.83e-03 | 235 | 102 | 6 | PS50026 | |
| Domain | SH3_1 | 2.06e-03 | 164 | 102 | 5 | PF00018 | |
| Domain | WW | 2.15e-03 | 47 | 102 | 3 | PF00397 | |
| Domain | WW | 2.29e-03 | 48 | 102 | 3 | SM00456 | |
| Domain | EGF-like_dom | 2.45e-03 | 249 | 102 | 6 | IPR000742 | |
| Domain | WW_DOMAIN_1 | 2.72e-03 | 51 | 102 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.72e-03 | 51 | 102 | 3 | PS50020 | |
| Domain | WW_dom | 2.88e-03 | 52 | 102 | 3 | IPR001202 | |
| Domain | EGF-like_CS | 3.09e-03 | 261 | 102 | 6 | IPR013032 | |
| Domain | EGF_2 | 3.34e-03 | 265 | 102 | 6 | PS01186 | |
| Domain | ATPase_P-typ_TM_dom | 3.37e-03 | 16 | 102 | 2 | IPR023298 | |
| Domain | - | 3.37e-03 | 16 | 102 | 2 | 1.20.1110.10 | |
| Domain | FN3 | 3.47e-03 | 185 | 102 | 5 | SM00060 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.81e-03 | 17 | 102 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.81e-03 | 17 | 102 | 2 | PF00689 | |
| Domain | Cation_ATPase_N | 4.27e-03 | 18 | 102 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 4.27e-03 | 18 | 102 | 2 | SM00831 | |
| Domain | FN3 | 4.72e-03 | 199 | 102 | 5 | PS50853 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.75e-03 | 19 | 102 | 2 | IPR004014 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.26e-10 | 18 | 75 | 6 | MM1549 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 5.51e-08 | 100 | 75 | 8 | MM14561 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.56e-08 | 141 | 75 | 9 | MM15266 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.15e-08 | 40 | 75 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 7.18e-08 | 41 | 75 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 8.34e-08 | 42 | 75 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 9.65e-08 | 43 | 75 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.67e-07 | 47 | 75 | 6 | MM14939 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.88e-07 | 117 | 75 | 8 | MM15387 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.16e-07 | 49 | 75 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.44e-07 | 50 | 75 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.76e-07 | 51 | 75 | 6 | MM15151 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.99e-07 | 129 | 75 | 8 | MM14894 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.36e-07 | 55 | 75 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.02e-07 | 58 | 75 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.02e-07 | 58 | 75 | 6 | MM14736 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.18e-06 | 202 | 75 | 9 | MM15362 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.19e-06 | 65 | 75 | 6 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.38e-06 | 73 | 75 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 4.71e-06 | 82 | 75 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.42e-06 | 84 | 75 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.21e-06 | 86 | 75 | 6 | MM15413 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 8.22e-06 | 193 | 75 | 8 | MM14890 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 8.51e-06 | 257 | 75 | 9 | MM14755 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.19e-06 | 92 | 75 | 6 | MM14951 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.30e-05 | 271 | 75 | 9 | MM15406 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.13e-05 | 114 | 75 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.31e-05 | 234 | 75 | 8 | MM14898 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 9.32e-05 | 271 | 75 | 8 | MM15388 | |
| Pathway | REACTOME_M_PHASE | 2.05e-04 | 387 | 75 | 9 | MM15364 | |
| Pathway | REACTOME_SUMOYLATION | 2.76e-04 | 169 | 75 | 6 | MM14919 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD2 RANBP2 RGPD8 ARHGAP26 RGPD1 ARHGAP11A RGPD3 SGO2 DAAM1 DYNC1H1 | 6.04e-04 | 649 | 75 | 11 | MM15690 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 6.65e-04 | 277 | 75 | 7 | MM15414 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.78e-03 | 12 | 75 | 2 | M27326 | |
| Pubmed | RGPD4 RGPD2 FLNB RANBP2 HSP90B1 RGPD8 COPG1 RGPD1 KPRP FAM98A CMYA5 SBSN DDX1 EHD4 P4HB AHNAK RGPD3 SEC16A POLDIP2 HAL DMD DYNC1H1 RGPD5 | 8.98e-16 | 844 | 106 | 23 | 25963833 | |
| Pubmed | RGPD4 RGPD2 FLNB RANBP2 HSP90B1 ELOA2 RGPD8 FBF1 RGPD1 MAGI3 FAM98A TEX14 INSYN2A DDX1 EHD4 ANTXR2 GTF3C1 P4HB AHNAK RGPD3 ANKRD30A DLG1 DLG2 DMD ATP2B2 PRRC2B RAI1 RGPD5 | 2.23e-15 | 1442 | 106 | 28 | 35575683 | |
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 21205196 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 18949001 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 25187515 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 9037092 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 4.85e-15 | 7 | 106 | 6 | 15710750 | |
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 26632511 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 24403063 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.85e-15 | 7 | 106 | 6 | 11353387 | |
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 30944974 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 38838144 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.85e-15 | 7 | 106 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.85e-15 | 7 | 106 | 6 | 17372272 | |
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 38657106 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 12191015 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 22821000 | ||
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 20682751 | ||
| Pubmed | TRERF1 RGPD4 RGPD2 FLNB RANBP2 RGPD8 CD2AP ATG2B RGPD1 CHD7 CIC RBM20 GTF3C1 AHNAK RGPD3 SEC16A CAMSAP1 | 1.21e-14 | 418 | 106 | 17 | 34709266 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.93e-14 | 8 | 106 | 6 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.93e-14 | 8 | 106 | 6 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.93e-14 | 8 | 106 | 6 | 28745977 | |
| Pubmed | 1.93e-14 | 8 | 106 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.93e-14 | 8 | 106 | 6 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.79e-14 | 9 | 106 | 6 | 18394993 | |
| Pubmed | 5.79e-14 | 9 | 106 | 6 | 11553612 | ||
| Pubmed | 5.79e-14 | 9 | 106 | 6 | 10601307 | ||
| Pubmed | 5.79e-14 | 9 | 106 | 6 | 9733766 | ||
| Pubmed | 5.79e-14 | 9 | 106 | 6 | 28100513 | ||
| Pubmed | 5.79e-14 | 9 | 106 | 6 | 28877029 | ||
| Pubmed | 5.79e-14 | 9 | 106 | 6 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.44e-13 | 10 | 106 | 6 | 8857542 | |
| Pubmed | 1.44e-13 | 10 | 106 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.44e-13 | 10 | 106 | 6 | 16332688 | |
| Pubmed | 1.44e-13 | 10 | 106 | 6 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 3.17e-13 | 11 | 106 | 6 | 35771867 | |
| Pubmed | 3.17e-13 | 11 | 106 | 6 | 17069463 | ||
| Pubmed | 3.17e-13 | 11 | 106 | 6 | 34110283 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 CHD7 DDX1 SUPT6H RGPD3 SEC16A SGO2 | 9.62e-13 | 146 | 106 | 11 | 23892456 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.17e-12 | 13 | 106 | 6 | 31427429 | |
| Pubmed | RGPD4 RGPD2 FLNB RGPD8 CD2AP ATG2B RGPD1 RICTOR GTF3C1 AHNAK RGPD3 RGPD5 | 3.02e-12 | 215 | 106 | 12 | 35973513 | |
| Pubmed | 3.40e-12 | 15 | 106 | 6 | 14697343 | ||
| Pubmed | 6.07e-12 | 86 | 106 | 9 | 37253089 | ||
| Pubmed | TRERF1 RGPD4 CNTN4 FLII RGPD2 RANBP2 RGPD8 RGPD1 CHD7 EPS15L1 RGPD3 SEC16A DLG1 DLG2 CAMSAP1 ATP2B4 CDH10 DYNC1H1 PRRC2B RAI1 | 1.19e-11 | 963 | 106 | 20 | 28671696 | |
| Pubmed | RGPD4 FLII RGPD2 FLNB RANBP2 HSP90B1 RGPD8 COPG1 ATG2B ADGRB1 RGPD1 RICTOR TACC2 AKR7A2 EPS15L1 P4HB RGPD3 DLG1 DLG2 DAAM1 CAMSAP1 | 3.12e-11 | 1139 | 106 | 21 | 36417873 | |
| Pubmed | 4.98e-11 | 22 | 106 | 6 | 27717094 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 FLII FLNB RANBP2 HSP90B1 RGPD8 COPG1 CHD7 FAM98A DDX1 EHD4 AHNAK RGPD3 SEC16A DYNC1H1 RGPD5 | 8.29e-11 | 626 | 106 | 16 | 33644029 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD2 RANBP2 CHERP RGPD8 COPG1 CD2AP RGPD1 TACC2 NEDD1 EPS15L1 GTF3C1 P4HB AHNAK RGPD3 SMARCB1 SGO2 DYNC1H1 PRRC2B RGPD5 | 2.93e-10 | 1155 | 106 | 20 | 20360068 |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 11274188 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 FLII RGPD2 FLNB RANBP2 HSP90B1 COPG1 RGPD1 KPRP P4HB AHNAK SEC16A DAAM1 ATP2B4 DYNC1H1 | 1.28e-09 | 647 | 106 | 15 | 26618866 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.77e-09 | 38 | 106 | 6 | 12791264 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB RANBP2 COPG1 ARHGAP26 NEDD1 PGD SBSN PTPN4 GTF3C1 P4HB LPP SEC16A DLG1 DMD EDEM1 PRRC2B SORL1 | 6.59e-09 | 974 | 106 | 17 | 28675297 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNB RANBP2 CD2AP ATG2B MYOF EPS15L1 AHNAK SEC16A DLG1 DYNC1H1 | 6.71e-09 | 256 | 106 | 10 | 33397691 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 9.16e-09 | 135 | 106 | 8 | 31077711 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.04e-08 | 268 | 106 | 10 | 33024031 | |
| Pubmed | FLII FLNB CD2AP ATG2B ARHGAP11A WNK1 EPS15L1 AHNAK SEC16A SGO2 POLDIP2 CAMSAP1 USP48 RAI1 | 1.09e-08 | 645 | 106 | 14 | 25281560 | |
| Pubmed | COPG1 ARHGAP26 CD2AP KPRP MAGI3 FAM98A ARHGAP11A SBSN EPS15L1 P4HB AHNAK SEC16A DLG1 POLDIP2 DMD SORL1 | 1.90e-08 | 916 | 106 | 16 | 32203420 | |
| Pubmed | FLII FLNB HSP90B1 ARHGAP26 FAM98A DDX1 EPS15L1 FBXL16 C12orf50 P4HB SEC16A C1QC DLG1 DLG2 DMD ATP2B2 ATP2B4 DYNC1H1 PRRC2B | 6.18e-08 | 1431 | 106 | 19 | 37142655 | |
| Pubmed | FLII HSP90B1 CHERP COPG1 KPRP GBP2 FAM98A PGD MYOF P4HB SUPT6H SEC16A DMD DYNC1H1 | 7.55e-08 | 754 | 106 | 14 | 35906200 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.78e-08 | 332 | 106 | 10 | 32786267 | |
| Pubmed | FLNB RANBP2 CHERP COPG1 CHD7 GTF3C1 P4HB SUPT6H AHNAK SEC16A DYNC1H1 PRRC2B RAI1 | 1.03e-07 | 653 | 106 | 13 | 22586326 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 9480752 | ||
| Pubmed | RANBP2 HSP90B1 RICTOR CIC RBM20 EHD4 PTPN4 FBXL16 P4HB AHNAK LPP SEC16A DLG1 DMD ATP2B4 PRRC2B | 1.22e-07 | 1049 | 106 | 16 | 27880917 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 RANBP2 HSP90B1 RGPD1 KPRP CHD7 SEC16A SMARCB1 PRRC2B RAI1 | 1.30e-07 | 351 | 106 | 10 | 38297188 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 HSP90B1 CHERP ATG2B TACC2 NEDD1 WNK1 CIC SNX29 EPS15L1 AHNAK LPP SEC16A CAMSAP1 PRRC2B | 1.63e-07 | 934 | 106 | 15 | 33916271 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB RANBP2 COPG1 CD2AP KPRP FAM98A WNK1 PGD EHD4 MYOF EPS15L1 P4HB AHNAK LPP SEC16A DLG1 HAL PRRC2B | 1.63e-07 | 1367 | 106 | 18 | 32687490 |
| Pubmed | FLII FLNB HSP90B1 CD2AP EPS15L1 P4HB AHNAK LPP SEC16A DYNC1H1 | 1.65e-07 | 360 | 106 | 10 | 33111431 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RGPD2 RANBP2 RGPD8 CD2AP RGPD1 FAM98A GTF3C1 RGPD3 DYNC1H1 | 2.12e-07 | 370 | 106 | 10 | 22922362 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 FLII RGPD2 RANBP2 HSP90B1 RGPD8 COPG1 RGPD1 FAM98A DDX1 GTF3C1 P4HB RGPD3 SEC16A SMARCB1 DYNC1H1 RGPD5 | 2.58e-07 | 1257 | 106 | 17 | 37317656 |
| Pubmed | FLNB RANBP2 HSP90B1 CD2AP ATG2B MAGI3 RICTOR EPS15L1 AHNAK SEC16A DLG1 CAMSAP1 DYNC1H1 | 2.59e-07 | 708 | 106 | 13 | 39231216 | |
| Pubmed | 3.48e-07 | 216 | 106 | 8 | 31519766 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RANBP2 HSP90B1 CD2AP CHD7 DDX1 GTF3C1 AHNAK SMARCB1 USP48 RAI1 | 3.77e-07 | 394 | 106 | 10 | 27248496 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLII FLNB HSP90B1 COPG1 CD2AP GBP2 CMYA5 WNK1 PGD DDX1 EHD4 EPS15L1 P4HB AHNAK LPP SEC16A USP48 DYNC1H1 | 4.06e-07 | 1455 | 106 | 18 | 22863883 |
| Pubmed | 5.14e-07 | 312 | 106 | 9 | 37120454 | ||
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 12763866 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.78e-07 | 231 | 106 | 8 | 16452087 | |
| Pubmed | 6.19e-07 | 99 | 106 | 6 | 27746211 | ||
| Pubmed | 6.91e-07 | 162 | 106 | 7 | 15174051 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 RGPD2 FLNB RANBP2 RGPD8 COPG1 RGPD1 FAM98A CIC DDX1 RGPD3 DYNC1H1 | 9.27e-07 | 665 | 106 | 12 | 30457570 |
| Pubmed | CD2AP ATG2B EPS15L1 GTF3C1 AHNAK LPP SEC16A DLG1 DYNC1H1 PRRC2B RGPD5 | 9.88e-07 | 549 | 106 | 11 | 38280479 | |
| Pubmed | 1.07e-06 | 173 | 106 | 7 | 23979707 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNB CD2AP MAGI3 SBSN EHD4 EPS15L1 AHNAK LPP DLG1 DAAM1 ATP2B4 | 1.30e-06 | 565 | 106 | 11 | 25468996 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLII FLNB RANBP2 HSP90B1 CHERP COPG1 KPRP CMYA5 PGD DDX1 EHD4 GTF3C1 P4HB SUPT6H SGO2 POLDIP2 DYNC1H1 | 1.46e-06 | 1425 | 106 | 17 | 30948266 |
| Pubmed | 1.53e-06 | 263 | 106 | 8 | 34702444 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RGPD8 TACC2 CHD7 WNK1 CIC RBM20 DDX1 SUPT6H SEC16A PRRC2B SORL1 | 1.92e-06 | 588 | 106 | 11 | 38580884 |
| Pubmed | 1.96e-06 | 272 | 106 | 8 | 31010829 | ||
| Pubmed | FLII HSP90B1 COPG1 RICTOR SBSN DDX1 GTF3C1 AHNAK LPP SEC16A DYNC1H1 | 2.37e-06 | 601 | 106 | 11 | 33658012 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 2.45e-06 | 377 | 106 | 9 | 38117590 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNB DPYS CD2AP UBXN6 KPRP PGD BGN EHD4 AKR7A2 MYOF EYS AHNAK DYNC1H1 SORL1 | 2.63e-06 | 1016 | 106 | 14 | 19056867 |
| Pubmed | 2.88e-06 | 494 | 106 | 10 | 26831064 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLII FLNB RANBP2 HSP90B1 CHERP KPRP DDX1 EHD4 GTF3C1 P4HB SUPT6H AHNAK SEC16A DYNC1H1 | 2.88e-06 | 1024 | 106 | 14 | 24711643 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.01e-06 | 202 | 106 | 7 | 33005030 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLII FLNB RANBP2 HSP90B1 COPG1 RICTOR CHD7 FAM98A PGD DDX1 EHD4 GTF3C1 P4HB AHNAK SEC16A DYNC1H1 | 3.44e-06 | 1353 | 106 | 16 | 29467282 |
| Pubmed | 3.72e-06 | 397 | 106 | 9 | 21319273 | ||
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 4.45e-06 | 36 | 106 | 4 | 26053890 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLII FLNB RANBP2 HSP90B1 COPG1 TACC2 FAM98A WNK1 DDX1 P4HB SUPT6H AHNAK LPP SEC16A POLDIP2 DYNC1H1 | 6.05e-06 | 1415 | 106 | 16 | 28515276 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 6.30e-06 | 226 | 106 | 7 | 37839992 | |
| Interaction | RGPD4 interactions | 1.15e-13 | 22 | 104 | 8 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 7.83e-13 | 27 | 104 | 8 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 1.02e-10 | 47 | 104 | 8 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 1.45e-10 | 49 | 104 | 8 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 1.53e-10 | 74 | 104 | 9 | int:RGPD8 | |
| Interaction | MCM2 interactions | RGPD4 RGPD2 FLNB RANBP2 HSP90B1 RGPD8 COPG1 ATG2B RGPD1 FAM98A CMYA5 SBSN DDX1 EHD4 EPS15L1 P4HB AHNAK RGPD3 SEC16A POLDIP2 HAL DMD DYNC1H1 RGPD5 | 9.41e-10 | 1081 | 104 | 24 | int:MCM2 |
| Interaction | RGPD5 interactions | 1.63e-09 | 96 | 104 | 9 | int:RGPD5 | |
| Interaction | RICTOR interactions | RGPD4 RGPD2 FLNB HSP90B1 RGPD8 COPG1 CD2AP UBXN6 ATG2B RGPD1 KPRP RICTOR MYOF GTF3C1 P4HB AHNAK RGPD3 SEC16A DYNC1H1 RGPD5 | 1.67e-09 | 759 | 104 | 20 | int:RICTOR |
| Interaction | PHLPP1 interactions | FLNB RANBP2 CD2AP ATG2B CMYA5 MYOF EPS15L1 AHNAK SEC16A DLG1 DYNC1H1 | 1.21e-06 | 333 | 104 | 11 | int:PHLPP1 |
| Interaction | NPIPB6 interactions | 1.94e-06 | 18 | 104 | 4 | int:NPIPB6 | |
| Interaction | GSK3B interactions | HSP90B1 COPG1 UBXN6 ATG2B RGPD1 GBP2 RICTOR SNX29 MYOF P4HB LPP SEC16A POLDIP2 EDEM1 CAMSAP1 USP48 RAI1 | 2.09e-06 | 868 | 104 | 17 | int:GSK3B |
| Interaction | RANBP2 interactions | RGPD4 RGPD2 RANBP2 CHERP RGPD8 RGPD1 WNK1 CIC RGPD3 RGPD5 TBX5 | 2.64e-06 | 361 | 104 | 11 | int:RANBP2 |
| Interaction | HSF1 interactions | FLII RANBP2 HSP90B1 CHERP COPG1 PGD DDX1 AKR7A2 MYOF EPS15L1 SUPT6H SEC16A SMARCB1 PRRC2B | 2.97e-06 | 609 | 104 | 14 | int:HSF1 |
| Interaction | BTF3 interactions | RGPD4 FLII FLNB RANBP2 HSP90B1 RGPD8 COPG1 CHD7 FAM98A DDX1 EHD4 AHNAK RGPD3 SEC16A DYNC1H1 RGPD5 | 3.26e-06 | 799 | 104 | 16 | int:BTF3 |
| Interaction | SIRT6 interactions | FLNB RANBP2 RGPD8 KIAA0232 FAT3 RICTOR GTF3C1 SUPT6H SEC16A SGO2 EDEM1 CAMSAP1 USP48 RGPD5 | 4.23e-06 | 628 | 104 | 14 | int:SIRT6 |
| Interaction | FGFRL1 interactions | 7.83e-06 | 53 | 104 | 5 | int:FGFRL1 | |
| Interaction | AURKB interactions | FLII RANBP2 HSP90B1 CHERP CMYA5 WNK1 CIC DDX1 GTF3C1 P4HB AHNAK SEC16A POLDIP2 USP48 DYNC1H1 | 8.26e-06 | 761 | 104 | 15 | int:AURKB |
| Interaction | RCOR1 interactions | FLII RANBP2 CD2AP ATG2B CHD7 CIC RBM20 AHNAK SEC16A SMARCB1 CAMSAP1 TBX5 | 9.22e-06 | 494 | 104 | 12 | int:RCOR1 |
| Interaction | SUMO2 interactions | FLNB RANBP2 HSP90B1 COPG1 PGD CIC DDX1 EHD4 GTF3C1 P4HB AHNAK USP48 DYNC1H1 | 1.11e-05 | 591 | 104 | 13 | int:SUMO2 |
| Interaction | MYCBPAP interactions | 1.44e-05 | 29 | 104 | 4 | int:MYCBPAP | |
| Interaction | CFTR interactions | RGPD4 FLII RGPD2 FLNB RANBP2 HSP90B1 COPG1 RGPD1 KPRP DDX1 ZDHHC15 ANTXR2 P4HB AHNAK SEC16A DLG1 DAAM1 DMD ATP2B4 DYNC1H1 SORL1 | 1.85e-05 | 1480 | 104 | 21 | int:CFTR |
| Interaction | BRCA1 interactions | CNTN4 FLII FLNB HSP90B1 COPG1 INPP1 PEG3 RICTOR FAM98A PGD DDX1 P4HB SUPT6H AHNAK SEC16A SMARCB1 SGO2 USP48 DYNC1H1 | 1.90e-05 | 1249 | 104 | 19 | int:BRCA1 |
| Interaction | FMNL1 interactions | 2.15e-05 | 109 | 104 | 6 | int:FMNL1 | |
| Interaction | KDM1A interactions | TRERF1 FLII FLNB RANBP2 CD2AP ATG2B CHD7 CIC RBM20 DDX1 GTF3C1 AHNAK SEC16A SMARCB1 CAMSAP1 TBX5 | 2.51e-05 | 941 | 104 | 16 | int:KDM1A |
| Interaction | ALB interactions | 3.48e-05 | 391 | 104 | 10 | int:ALB | |
| Interaction | KCNA3 interactions | FLNB RANBP2 HSP90B1 CD2AP ATG2B MAGI3 RICTOR EPS15L1 AHNAK SEC16A C1QC DLG1 CAMSAP1 DYNC1H1 SORL1 | 3.99e-05 | 871 | 104 | 15 | int:KCNA3 |
| Interaction | FZD7 interactions | 4.89e-05 | 77 | 104 | 5 | int:FZD7 | |
| Interaction | TAS2R7 interactions | 5.81e-05 | 15 | 104 | 3 | int:TAS2R7 | |
| Interaction | HSD17B6 interactions | 5.81e-05 | 15 | 104 | 3 | int:HSD17B6 | |
| Interaction | DISC1 interactions | 7.56e-05 | 429 | 104 | 10 | int:DISC1 | |
| Interaction | KCTD13 interactions | FLII FLNB HSP90B1 ARHGAP26 FAM98A DDX1 EPS15L1 FBXL16 C12orf50 P4HB SEC16A C1QC DLG1 DLG2 DMD ATP2B2 ATP2B4 DYNC1H1 PRRC2B | 8.47e-05 | 1394 | 104 | 19 | int:KCTD13 |
| Interaction | MYBPC2 interactions | 8.47e-05 | 45 | 104 | 4 | int:MYBPC2 | |
| Interaction | LRRC31 interactions | 9.39e-05 | 205 | 104 | 7 | int:LRRC31 | |
| Interaction | KIF20A interactions | RGPD4 FLII FLNB RANBP2 CHERP RGPD8 FAM98A DDX1 P4HB SUPT6H AHNAK RGPD3 SEC16A SMARCB1 TET3 PRRC2B | 9.47e-05 | 1052 | 104 | 16 | int:KIF20A |
| Interaction | SOX2 interactions | TRERF1 FLII RANBP2 ARHGAP26 CHD7 FAM98A PSPH PGD CIC DDX1 EHD4 GTF3C1 P4HB SEC16A SMARCB1 SGO2 POLDIP2 HAL PRRC2B | 1.10e-04 | 1422 | 104 | 19 | int:SOX2 |
| Interaction | SIRT7 interactions | FLNB RANBP2 CHERP COPG1 CHD7 GTF3C1 P4HB SUPT6H AHNAK SEC16A DYNC1H1 PRRC2B RAI1 | 1.18e-04 | 744 | 104 | 13 | int:SIRT7 |
| Interaction | FZD4 interactions | 1.22e-04 | 19 | 104 | 3 | int:FZD4 | |
| Interaction | KCNJ4 interactions | 1.43e-04 | 20 | 104 | 3 | int:KCNJ4 | |
| Interaction | NAA40 interactions | RANBP2 HSP90B1 CHERP ATG2B TACC2 NEDD1 WNK1 CIC SNX29 EPS15L1 AHNAK LPP SEC16A CAMSAP1 PRRC2B | 1.46e-04 | 978 | 104 | 15 | int:NAA40 |
| Interaction | CDCP2 interactions | 1.57e-04 | 4 | 104 | 2 | int:CDCP2 | |
| Interaction | RAN interactions | RGPD4 RGPD2 FLNB RANBP2 RGPD8 RGPD1 RGPD3 SMARCB1 USP48 RGPD5 | 1.74e-04 | 475 | 104 | 10 | int:RAN |
| Interaction | SP7 interactions | 1.80e-04 | 304 | 104 | 8 | int:SP7 | |
| Interaction | DUSP16 interactions | 2.30e-04 | 237 | 104 | 7 | int:DUSP16 | |
| Interaction | ISG15 interactions | 2.38e-04 | 494 | 104 | 10 | int:ISG15 | |
| Interaction | LIN7A interactions | 2.45e-04 | 59 | 104 | 4 | int:LIN7A | |
| Interaction | DSCAM interactions | 2.61e-04 | 171 | 104 | 6 | int:DSCAM | |
| Interaction | ARHGAP36 interactions | 3.12e-04 | 114 | 104 | 5 | int:ARHGAP36 | |
| Interaction | ERN2 interactions | 3.18e-04 | 26 | 104 | 3 | int:ERN2 | |
| Interaction | MAPRE1 interactions | FLNB RANBP2 CD2AP TACC2 LPP SEC16A CAMSAP1 DYNC1H1 PRRC2B RGPD5 | 3.26e-04 | 514 | 104 | 10 | int:MAPRE1 |
| Interaction | WWTR1 interactions | 3.38e-04 | 422 | 104 | 9 | int:WWTR1 | |
| Interaction | NUP35 interactions | 3.50e-04 | 424 | 104 | 9 | int:NUP35 | |
| Interaction | HNRNPM interactions | FLII FLNB RANBP2 RICTOR CIC DDX1 GTF3C1 AHNAK SEC16A SMARCB1 USP48 TBX5 | 3.50e-04 | 723 | 104 | 12 | int:HNRNPM |
| Interaction | BICD2 interactions | 3.62e-04 | 426 | 104 | 9 | int:BICD2 | |
| Interaction | FBXO42 interactions | 3.93e-04 | 259 | 104 | 7 | int:FBXO42 | |
| Interaction | KCNJ12 interactions | 3.98e-04 | 28 | 104 | 3 | int:KCNJ12 | |
| Interaction | PDZD11 interactions | 4.00e-04 | 67 | 104 | 4 | int:PDZD11 | |
| Interaction | C9orf72 interactions | RGPD4 FLII RGPD2 RANBP2 HSP90B1 RGPD8 COPG1 RGPD1 FAM98A DDX1 GTF3C1 P4HB RGPD3 SEC16A SMARCB1 DYNC1H1 RGPD5 | 4.04e-04 | 1319 | 104 | 17 | int:C9orf72 |
| Interaction | PHF21A interactions | 4.05e-04 | 343 | 104 | 8 | int:PHF21A | |
| Interaction | EYA2 interactions | 4.11e-04 | 121 | 104 | 5 | int:EYA2 | |
| Interaction | GATA3 interactions | 4.21e-04 | 187 | 104 | 6 | int:GATA3 | |
| Interaction | PDE6B interactions | 4.42e-04 | 29 | 104 | 3 | int:PDE6B | |
| Interaction | FMR1 interactions | 4.54e-04 | 536 | 104 | 10 | int:FMR1 | |
| Interaction | BIRC3 interactions | FLII FLNB RANBP2 HSP90B1 CHERP COPG1 KPRP CMYA5 PGD DDX1 EHD4 GTF3C1 P4HB SUPT6H SGO2 POLDIP2 DYNC1H1 | 4.60e-04 | 1334 | 104 | 17 | int:BIRC3 |
| Interaction | GBF1 interactions | 4.73e-04 | 442 | 104 | 9 | int:GBF1 | |
| Interaction | SYNE3 interactions | 4.88e-04 | 444 | 104 | 9 | int:SYNE3 | |
| Interaction | RNF2 interactions | FLNB RANBP2 COPG1 RICTOR CIC GTF3C1 P4HB LPP SEC16A SMARCB1 SGO2 DYNC1H1 TBX5 | 5.13e-04 | 866 | 104 | 13 | int:RNF2 |
| Interaction | DLG4 interactions | 5.29e-04 | 449 | 104 | 9 | int:DLG4 | |
| Interaction | DCTN3 interactions | 5.32e-04 | 128 | 104 | 5 | int:DCTN3 | |
| Interaction | MED4 interactions | 5.38e-04 | 450 | 104 | 9 | int:MED4 | |
| Interaction | ZBBX interactions | 5.40e-04 | 31 | 104 | 3 | int:ZBBX | |
| Interaction | ACTR1A interactions | 5.50e-04 | 274 | 104 | 7 | int:ACTR1A | |
| Interaction | RPA4 interactions | 5.55e-04 | 452 | 104 | 9 | int:RPA4 | |
| Interaction | CCDC8 interactions | FLII FLNB RANBP2 HSP90B1 KPRP EHD4 GTF3C1 P4HB AHNAK SEC16A DYNC1H1 | 5.74e-04 | 656 | 104 | 11 | int:CCDC8 |
| Interaction | AKIRIN2 interactions | 5.84e-04 | 74 | 104 | 4 | int:AKIRIN2 | |
| Interaction | MAP2K2 interactions | 5.99e-04 | 278 | 104 | 7 | int:MAP2K2 | |
| Interaction | MST1R interactions | 6.00e-04 | 200 | 104 | 6 | int:MST1R | |
| Cytoband | 10q26.2 | 3.43e-04 | 12 | 106 | 2 | 10q26.2 | |
| Cytoband | 2q13 | 5.38e-04 | 68 | 106 | 3 | 2q13 | |
| Cytoband | 2q12.3 | 7.02e-04 | 17 | 106 | 2 | 2q12.3 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.04e-07 | 115 | 73 | 7 | 769 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.54e-04 | 26 | 73 | 3 | 904 | |
| GeneFamily | PDZ domain containing | 3.73e-04 | 152 | 73 | 5 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 4.72e-04 | 160 | 73 | 5 | 555 | |
| GeneFamily | ATPases Ca2+ transporting | 5.68e-04 | 9 | 73 | 2 | 1209 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 3.84e-09 | 33 | 106 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 2.05e-08 | 43 | 106 | 6 | MM3857 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | FLII FLNB ARHGAP26 MYOF P4HB SUPT6H AHNAK SEC16A DAAM1 ATP2B4 DYNC1H1 | 1.50e-06 | 433 | 106 | 11 | M2240 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 RGPD2 FLNB RANBP2 RGPD8 INPP1 ARHGAP26 RGPD1 CHD7 RGPD3 DAAM1 | 1.57e-06 | 435 | 106 | 11 | MM1221 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RGPD2 RANBP2 CHERP RGPD8 RGPD1 RICTOR RGPD3 LPP USP48 RGPD5 | 3.58e-06 | 474 | 106 | 11 | M40991 |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP | 1.75e-05 | 200 | 106 | 7 | M9944 | |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP | 1.87e-05 | 135 | 106 | 6 | M8793 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 2.50e-05 | 85 | 106 | 5 | M41085 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 3.12e-05 | 89 | 106 | 5 | M40280 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CNTN4 PEG3 ADGRB1 MAGI3 RICTOR INSYN2A EHD4 SGK2 FBXL16 CNTN5 DLG2 DAAM1 ATP2B2 PRRC2B RAI1 | 3.87e-05 | 1106 | 106 | 15 | M39071 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | RGPD4 RGPD2 RANBP2 HSP90B1 ELOA2 RGPD8 COPG1 INPP1 RGPD1 GBP2 CFAP43 ARHGAP11A RGPD3 POLDIP2 EDEM1 USP48 | 5.39e-05 | 1277 | 106 | 16 | MM1032 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN | 1.10e-04 | 116 | 106 | 5 | M17778 | |
| Coexpression | HOXA9_DN.V1_UP | 1.33e-04 | 192 | 106 | 6 | M2850 | |
| Coexpression | GSE12366_NAIVE_VS_MEMORY_BCELL_DN | 1.37e-04 | 193 | 106 | 6 | M3181 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.61e-04 | 199 | 106 | 6 | M7877 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP | 1.61e-04 | 199 | 106 | 6 | M9038 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 1.61e-04 | 199 | 106 | 6 | M6964 | |
| Coexpression | GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.66e-04 | 200 | 106 | 6 | M299 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 1.66e-04 | 200 | 106 | 6 | M5973 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN | 1.66e-04 | 200 | 106 | 6 | M6258 | |
| Coexpression | GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN | 1.66e-04 | 200 | 106 | 6 | M3435 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_DN | 1.66e-04 | 200 | 106 | 6 | M5748 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 1.75e-04 | 128 | 106 | 5 | M6083 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-07 | 176 | 106 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.75e-07 | 182 | 106 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.85e-07 | 183 | 106 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.85e-07 | 183 | 106 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-07 | 184 | 106 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.42e-07 | 188 | 106 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.54e-07 | 189 | 106 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.94e-07 | 192 | 106 | 7 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.94e-07 | 192 | 106 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.08e-07 | 193 | 106 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-07 | 193 | 106 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-07 | 193 | 106 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-07 | 194 | 106 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.37e-07 | 195 | 106 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.37e-07 | 195 | 106 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 4.85e-07 | 198 | 106 | 7 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-06 | 157 | 106 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 159 | 106 | 6 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 177 | 106 | 6 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-06 | 181 | 106 | 6 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 181 | 106 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-06 | 183 | 106 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.24e-06 | 184 | 106 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.24e-06 | 184 | 106 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.24e-06 | 184 | 106 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.93e-06 | 188 | 106 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.11e-06 | 189 | 106 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.11e-06 | 189 | 106 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.30e-06 | 190 | 106 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-06 | 190 | 106 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-06 | 190 | 106 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.49e-06 | 191 | 106 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.69e-06 | 192 | 106 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 6.69e-06 | 192 | 106 | 6 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 192 | 106 | 6 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 192 | 106 | 6 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-06 | 193 | 106 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 194 | 106 | 6 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-06 | 194 | 106 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.09e-06 | 194 | 106 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.09e-06 | 194 | 106 | 6 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 194 | 106 | 6 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-06 | 194 | 106 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 7.09e-06 | 194 | 106 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 194 | 106 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 7.09e-06 | 194 | 106 | 6 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.30e-06 | 195 | 106 | 6 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-06 | 196 | 106 | 6 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-06 | 196 | 106 | 6 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.52e-06 | 196 | 106 | 6 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | moderate-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.97e-06 | 198 | 106 | 6 | 7ecce5e266bb08797088cc8f8309e0c7b48df5c9 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.20e-06 | 199 | 106 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.20e-06 | 199 | 106 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.20e-06 | 199 | 106 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.44e-06 | 200 | 106 | 6 | 2f1218c9884fabae952cdbff25b6baa7bae9e732 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.44e-06 | 200 | 106 | 6 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 2.70e-05 | 147 | 106 | 5 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 151 | 106 | 5 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-05 | 153 | 106 | 5 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-05 | 155 | 106 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 156 | 106 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.59e-05 | 156 | 106 | 5 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 159 | 106 | 5 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 4.17e-05 | 161 | 106 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-05 | 164 | 106 | 5 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 4.69e-05 | 165 | 106 | 5 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 170 | 106 | 5 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.41e-05 | 170 | 106 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 170 | 106 | 5 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-05 | 170 | 106 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-05 | 171 | 106 | 5 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-05 | 171 | 106 | 5 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.04e-05 | 174 | 106 | 5 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 175 | 106 | 5 | b227d4499274fb63b193d34de7f2d812e283e79d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 175 | 106 | 5 | 308ee4ef7b9ecea68efca011ef91aed0f1be0eca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 175 | 106 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-05 | 176 | 106 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.37e-05 | 176 | 106 | 5 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-05 | 176 | 106 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.37e-05 | 176 | 106 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 177 | 106 | 5 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 177 | 106 | 5 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.72e-05 | 178 | 106 | 5 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 180 | 106 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 180 | 106 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| Disease | urate measurement, bone density | CNTN4 HTR2A CD2AP MAGI3 SNX29 EYS LPP SEC16A DLG2 ATP2B2 ATP2B4 PRRC2B | 1.58e-06 | 619 | 102 | 12 | EFO_0003923, EFO_0004531 |
| Disease | carbohydrate measurement | 1.96e-05 | 46 | 102 | 4 | EFO_0004998 | |
| Disease | monocyte percentage of leukocytes | TRERF1 KIAA0232 CHD7 WNK1 SNX29 EHD4 EPS15L1 AHNAK LPP SEC16A MS4A14 | 4.62e-05 | 731 | 102 | 11 | EFO_0007989 |
| Disease | Smith-Magenis syndrome | 7.07e-05 | 4 | 102 | 2 | C0795864 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 1.18e-04 | 5 | 102 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | progressive supranuclear palsy | 1.68e-04 | 31 | 102 | 3 | MONDO_0019037 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.76e-04 | 6 | 102 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | cutaneous squamous cell carcinoma | 2.03e-04 | 33 | 102 | 3 | EFO_1001927 | |
| Disease | Autism Spectrum Disorders | 2.20e-04 | 85 | 102 | 4 | C1510586 | |
| Disease | benign neoplasm (implicated_via_orthology) | 3.27e-04 | 8 | 102 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | myeloid white cell count | FLNB ARHGAP26 CHD7 CIC EHD4 EPS15L1 ANTXR2 GTF3C1 CNTN5 ATP2B4 SORL1 | 4.01e-04 | 937 | 102 | 11 | EFO_0007988 |
| Disease | dilated cardiomyopathy (is_implicated_in) | 4.48e-04 | 43 | 102 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Familial dilated cardiomyopathy | 4.79e-04 | 44 | 102 | 3 | C0340427 | |
| Disease | Nephroblastoma | 5.23e-04 | 10 | 102 | 2 | Orphanet_654 | |
| Disease | eosinophil count | TRERF1 CHERP KIAA0232 ARHGAP26 CHD7 WNK1 SVEP1 EHD4 EPS15L1 ANTXR2 LPP SEC16A TET3 RAI1 | 6.01e-04 | 1488 | 102 | 14 | EFO_0004842 |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 6.38e-04 | 11 | 102 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | alcohol and nicotine codependence | 9.00e-04 | 13 | 102 | 2 | EFO_0004776 | |
| Disease | Malignant neoplasm of breast | TRERF1 FLNB TACC2 ARHGAP11A WNK1 CIC BGN ANKRD30A DMD CDH10 SORL1 | 1.23e-03 | 1074 | 102 | 11 | C0006142 |
| Disease | squamous cell carcinoma | 1.64e-03 | 67 | 102 | 3 | EFO_0000707 | |
| Disease | atrial fibrillation | 1.86e-03 | 371 | 102 | 6 | EFO_0000275 | |
| Disease | diet measurement, body mass index | 2.16e-03 | 20 | 102 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | adenosine diphosphate measurement | 2.16e-03 | 20 | 102 | 2 | EFO_0010452 | |
| Disease | lymphocyte:monocyte ratio | 3.30e-03 | 288 | 102 | 5 | EFO_0600088 | |
| Disease | pallidum volume | 3.37e-03 | 25 | 102 | 2 | EFO_0006933 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGAGFSDDPFKSKQD | 761 | Q9UBC2 | |
| DKDGKQPVGRFFGNS | 241 | O43488 | |
| FGELPGSGKLNKDAF | 1331 | Q8NDM7 | |
| FGGNPCEGPEKQTKF | 441 | O14514 | |
| TGKKNGNGEAGEFLP | 11 | Q15327 | |
| KDSGLPSQGLNFKFG | 596 | Q12959 | |
| PVFGLQDDSKVFKEG | 211 | P28223 | |
| KINGKLEESPDNDGF | 831 | Q9BXX3 | |
| DSKEQVFPVKGGFQA | 191 | P58335 | |
| SPFEVKVGVFNNKGE | 771 | Q8IWV2 | |
| GPQKFQFDGDKKSFL | 306 | P52209 | |
| TPDINIEGSEGKFKG | 3716 | Q09666 | |
| GELNGKEGVFPDNFA | 311 | Q9Y5K6 | |
| GGQKIKNEAEPEFAS | 1111 | P11532 | |
| SEGDQKPGVGFFFKD | 1261 | Q5T5Y3 | |
| KPGVGFFFKDEQKAE | 1266 | Q5T5Y3 | |
| GKDDFPGGVDNQELN | 616 | Q9P2D1 | |
| GTNDGPALKKADVGF | 821 | Q01814 | |
| GTNDGPALKKADVGF | 786 | P23634 | |
| GEGSQPFEGLEKFAE | 141 | Q96BY7 | |
| PFEVKVGVYNNKGDG | 846 | O94779 | |
| LQLDKGGNAKDFSPG | 671 | Q7Z5J4 | |
| DGFKFGISEPGNQEK | 1896 | P49792 | |
| GEGFQFGKKDPNFKG | 1956 | P49792 | |
| FPKEGVKAVGNGAAE | 961 | Q5T481 | |
| GFKFGISEPGNQEKK | 921 | Q99666 | |
| GFKFGISEPGNQEKK | 921 | O14715 | |
| NGFLTDAKEKNEAGP | 141 | Q6ZSG2 | |
| KPDENGRFGFNVKGG | 521 | P29074 | |
| GVFEVPKQNGKYETG | 66 | Q9Y2S7 | |
| PSDFKTDKEGGQAGS | 276 | Q8IYF1 | |
| ENKFPGLEKNIFGEE | 66 | P49441 | |
| KPGQFVFKGDLDINV | 1176 | Q14667 | |
| SGNDFKGGYFPENVK | 16 | Q13045 | |
| DEGAKGQKGESPNSF | 81 | A8MXT2 | |
| KGFGFAIADSPTGQK | 586 | Q5TCQ9 | |
| DLLPNGADFKNGFQG | 2561 | Q5T1H1 | |
| SIGKGDGFDFLPQLN | 426 | Q8NHV4 | |
| DKDGQPVSGAEGKFT | 4066 | Q8NDA2 | |
| ALGKDDFTKIPNGVN | 336 | Q14117 | |
| FIQQGGGPDKKGHQF | 526 | Q92499 | |
| GKAPLKIFAQDGEGQ | 676 | O75369 | |
| QPKSGENGLNKGFSF | 1001 | Q92628 | |
| ENSGFEPGAFDGLKL | 196 | P21810 | |
| EEAFKVQGNPGGKTL | 96 | Q93052 | |
| LEEDVKQGTFSKPGG | 416 | P32456 | |
| TEGPFNQGYGEGAKE | 421 | Q9H223 | |
| FKKFLESGGQDGAGD | 466 | P07237 | |
| PSIGENDLKFTKNFG | 1176 | Q6R327 | |
| EGSGEFKKDGEFSVP | 911 | Q9GZU2 | |
| GGVNFGEKDAKVPGT | 21 | E2RYF7 | |
| PEFDGKRFQNVAKEG | 581 | P14625 | |
| DGFKFGISEPGNQEK | 921 | A6NKT7 | |
| GEGFQFGKKDLNFKG | 981 | A6NKT7 | |
| GEPGEEGRYKQKFQS | 106 | P02747 | |
| GEEAGKIQPDEFFGI | 961 | Q9Y4D1 | |
| GFGDSPKAEKRQIGD | 216 | Q8TES7 | |
| IKNKPDNGGFTSVDD | 36 | P42357 | |
| EKQKDNPKFSFLFGG | 36 | Q8IWX8 | |
| SAVDKDDPLGGQKFF | 511 | Q9Y6N8 | |
| VFAGDGIEGSPAKDF | 261 | Q10981 | |
| SHPADFKKGGNQEIG | 1756 | Q8N3K9 | |
| VDGNDDGKFFIDPKT | 1296 | Q8TDW7 | |
| NADLKPIDGFNGRFG | 116 | A8MV24 | |
| KEFFSEEGGQDQGGK | 596 | Q92611 | |
| AKGEQYPEGQSKDGQ | 571 | Q96JA4 | |
| GTFDNAETKKEFGPV | 1091 | Q14204 | |
| GDQGNAFAGVKGEAK | 561 | Q5T749 | |
| NAKPGVIDSKGSFND | 616 | Q15700 | |
| NPDNFAIQLEKGGKF | 401 | P38567 | |
| DKKDEESGGGSNPFQ | 6 | Q9Y678 | |
| PDKQETELNGGFFKG | 836 | P82279 | |
| LKAFKEAEFGQGTGP | 976 | Q86VB7 | |
| AAGQVGKEAEKFGQG | 231 | Q6UWP8 | |
| AGQVGKEAEKFGQGA | 286 | Q6UWP8 | |
| FQIFPGAGEKGAKGE | 366 | P25940 | |
| GAKGEPAVIEKGQQF | 376 | P25940 | |
| GFKFGISEPGNQEKK | 906 | P0DJD0 | |
| EGFQFGKKDPNFKGF | 966 | P0DJD0 | |
| GKKDPNFKGFSGAGE | 971 | P0DJD0 | |
| PGGEKEFVNLQGFAA | 151 | Q8N461 | |
| QGGRVKVDVPNKFGF | 131 | Q8TC84 | |
| DGFKFGISEPGNQEK | 921 | Q7Z3J3 | |
| GEGFQFGKKDPNFKG | 981 | Q7Z3J3 | |
| VGDFVSGALNKFKPN | 286 | Q6P4F7 | |
| AGFKKIEVANPDGDF | 851 | Q92673 | |
| VFNLDGKDFLQGPVK | 351 | Q32P41 | |
| QNSGDVFKKTPGAGE | 276 | Q8TEQ0 | |
| ENDEPRGNGKFDKTG | 996 | Q8IWB6 | |
| QPTDFDFLKVIGKGN | 31 | Q9HBY8 | |
| KIENNPFAKGFRGSD | 226 | Q99593 | |
| TSGEGFQFGKKDPNF | 971 | P0DJD1 | |
| PKKAQEGGGSEVFQE | 131 | Q8NCA5 | |
| ADKKDPQGNGTVAGF | 206 | O60861 | |
| VPFDQKSGGKGGEDE | 301 | Q9UNA1 | |
| GQKPVKFQLEDDGEF | 11 | Q12824 | |
| GKRGAEDPGFIFNNE | 441 | Q562F6 | |
| EQDKKGEGFSPAESF | 1556 | Q4LDE5 | |
| GNLLEKPEGEDGFTF | 521 | Q8N1H7 | |
| DAQGLKAGDGPQFQF | 231 | Q9UNK9 | |
| GEDPEGNKGFGRKVF | 481 | Q96RK0 | |
| KPKTDIAAFENGGGD | 186 | Q8NA57 | |
| AKKFGLTPEQFGENL | 536 | Q7KZ85 | |
| QEFKADIKFKSAGPG | 6 | Q9BZV1 | |
| EKDIYGPGFKDNFQG | 71 | A0JD36 | |
| GPGFKDNFQGDIDIA | 76 | A0JD36 | |
| FDETQPTAESGGKGK | 146 | P78330 | |
| VGKPEDEASGSFFKQ | 551 | O15027 | |
| EFPTLKAAGGQDKAG | 171 | Q5JSZ5 | |
| GGFESQEKEAAGGFP | 221 | O95359 | |
| EANGVDGDGLNKPAK | 2406 | O95359 | |
| DFNSALKGSPGFQDK | 1541 | O43151 | |
| AGPKEEEFNASFKDG | 886 | O60290 | |
| GFSGSQKLEGEFKQP | 1216 | Q9H4A3 | |
| GLLQFGPTEKFQDKD | 976 | Q12789 | |
| GEKDPDFNQSNGGTK | 901 | Q86UV5 | |
| GPEKNGFNLGFIKNI | 256 | Q96MV8 | |
| GQPKGAFGEQFDAKN | 496 | Q96PN7 | |
| GGNADKKNLVDPFVE | 386 | Q9NZM1 |